Zhang H, et al. Global burden of metabolic diseases, 1990–2021. Metabolism. 2024;160:155999.
Article CAS PubMed Google Scholar
Sharma BR, Kanneganti T-D. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550–9.
Article CAS PubMed PubMed Central Google Scholar
Du L, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):212.
Article CAS PubMed PubMed Central Google Scholar
Yang J, et al. The predictive value of TyG and lipid ratios on the development of complications and hyperuricemia in patients with type 2 diabetes mellitus. Lipids. 2024;59(6):209–19.
Article CAS PubMed Google Scholar
Allegrini S, et al. The good, the bad and the new about uric acid in cancer. Cancers. 2022;14(19):4959.
Article CAS PubMed PubMed Central Google Scholar
Dovell F, Boffetta P. Serum uric acid and cancer mortality and incidence: a systematic review and meta-analysis. Eur J Cancer Prev. 2018;27(4):399–405.
Article CAS PubMed Google Scholar
Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab. 2020;319(5):E827-e834.
Article CAS PubMed Google Scholar
Cicero AFG, et al. Purine metabolism dysfunctions: Experimental methods of detection and diagnostic potential. Int J Mol Sci. 2023;24(8):7027.
Article CAS PubMed PubMed Central Google Scholar
Kim MJ, Mayr M. Uric acid and kidneys – Physiological and pathophysiological aspects. Therapeutische Umschau. Revue Ther. 2016;73(3):167–75.
Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol. 2014;29(6):999–1008.
Dai Y, Lee C-H. Transport mechanism and structural pharmacology of human urate transporter URAT1. Cell Res. 2024;34(11):776–87.
Article CAS PubMed PubMed Central Google Scholar
Song D, et al. A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications. Eur J Pharmacol. 2021;907:174291.
Article CAS PubMed Google Scholar
Chung S, Kim GH. Urate transporters in the kidney: What clinicians need to know. Electrolyte Blood Press. 2021;19(1):1–9.
Article CAS PubMed PubMed Central Google Scholar
Yiu A, et al. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study. Oncotarget. 2017;8(26):42332–42.
Article PubMed PubMed Central Google Scholar
Horsfall LJ, Nazareth I, Petersen I. Serum uric acid and the risk of respiratory disease: a population-based cohort study. Thorax. 2014;69(11):1021–6.
Strasak AM, et al. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men. Ann Epidemiol. 2009;19(1):15–24.
Benli E, et al. Comparison of serum uric acid levels between prostate cancer patients and a control group. Cent European J Urol. 2018;71(2):242–7.
CAS PubMed PubMed Central Google Scholar
Deng Z, et al. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study. Diabetes Metab Res Rev. 2016;32(3):325–32.
Article CAS PubMed Google Scholar
Yang J, et al. Association of serum uric acid with increased risk of cancer among hypertensive Chinese. Int J Cancer. 2017;141(1):112–20.
Article CAS PubMed Google Scholar
Wang A, et al. Serum urate, genetic variation, and prostate cancer risk: Atherosclerosis risk in communities (ARIC) study. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1259–61.
Article CAS PubMed PubMed Central Google Scholar
Lawal AO, Kolude B, Adeyemi BF. Serum uric Acid levels in oral cancer patients seen at tertiary institution in Nigeria. Ann Ib Postgrad Med. 2012;10(1):9–12.
CAS PubMed PubMed Central Google Scholar
Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res. 1988;48(10):2916–8.
Kobylecki CJ, Afzal S, Nordestgaard BG. Plasma urate, cancer incidence, and all-cause mortality: A Mendelian randomization study. Clin Chem. 2017;63(6):1151–60.
Article CAS PubMed Google Scholar
Kolonel LN, et al. Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Cancer Epidemiol Biomarkers Prev. 1994;3(3):225–8.
Boffetta P, et al. A prospective study of gout and cancer. Eur J Cancer Prev. 2009;18(2):127–32.
Chen CJ, et al. Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study. Eur J Cancer Prev. 2016;25(3):216–23.
Article CAS PubMed Google Scholar
Kuo CF, et al. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013;52(1):127–34.
Article CAS PubMed Google Scholar
Chuang JP, et al. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study. BMJ Open. 2019;9(10):e028892.
Article PubMed PubMed Central Google Scholar
Mi N, et al. High serum uric acid may associate with the increased risk of colorectal cancer in females: A prospective cohort study. Int J Cancer. 2022;150(2):263–72.
Article CAS PubMed Google Scholar
Huang CF, et al. Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study. World J Gastroenterol. 2020;26(44):7061–75.
Article CAS PubMed PubMed Central Google Scholar
Dai XY, et al. Serum uric acid levels and risk of kidney cancer incidence and mortality: A prospective cohort study. Cancer Med. 2020;9(15):5655–61.
Article CAS PubMed PubMed Central Google Scholar
Deng Y, Huang J, Wong MCS. Association between serum uric acid and prostate cancer risk in East Asian populations: a Mendelian randomization study. Eur J Nutr. 2023;62(3):1323–9.
Fan K, Sun T, Yin F. J-shaped association between uric acid and breast cancer risk: a prospective case-control study. J Cancer Res Clin Oncol. 2023;149(10):7629–36.
Comments (0)